This concept isn’t new—in fact, it is the essence of representational state transfer (REST). Instead of converting to a ...
A 13-year-old girl at a Louisiana middle school got into a fight with classmates who were sharing AI-generated nude images of ...
Beloved characters entering the public domain with the new year include Blondie, Dagwood, Dick and Jane and Nancy Drew, but ...
Disney has accused Google of copyright infringement on a "massive scale," alleging that the tech giant is training its AI tools on protected materials as well as allowing those tools to generate ...
A presentation accompanying the conference call discussing the transaction will be available on Gold Royalty's website at www.goldroyalty.com and a replay of the event will be available following the ...
The letter comes just as Disney announced it had reached a partnership with OpenAI. By Caitlin Huston Business Writer Disney has sent a cease-and-desist letter to Google accusing the tech giant of ...
This morning Disney and OpenAI announced a three-year licensing agreement: Starting in 2026, ChatGPT and Sora can generate images and videos incorporating Disney IP, including more than 200 characters ...
The share price of Sabine Royalty Trust (NYSE:SBR) fell by 9.17% between December 3 and December 10, 2025, putting it among the Energy Stocks that Lost the Most This Week. Sabine Royalty Trust ...
Katelyn is a writer with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...
Filed in federal court on Friday, the suit joins more than 40 other court disputes between copyright holders and A.I. companies. By Cade Metz and Michael M. Grynbaum Cade Metz reported from San ...
The DPIIT working paper said this would lower compliance costs for AI startups, reduce litigation risk, and create a level playing field between large and small players. It would also open a steady ...
In early December 2025, Denali Therapeutics announced a US$275 million synthetic royalty funding agreement with Royalty Pharma tied to future worldwide net sales of its investigational Hunter syndrome ...